Quadrant Capital Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-231
Closed -$57K 2896
2022
Q3
$57K Sell
231
-12
-5% -$3.24K 0.01% 973
2022
Q2
$60K Buy
243
+47
+24% +$12.7K 0.01% 816
2022
Q1
$65K Buy
196
+8
+4% +$2.46K 0.01% 833
2021
Q4
$68K Buy
188
+32
+21% +$10.8K 0.01% 806
2021
Q3
$51K Buy
156
+5
+3% +$1.69K 0.01% 858
2021
Q2
$47K Sell
151
-21
-12% -$6.44K 0.01% 868
2021
Q1
$55K Buy
172
+10
+6% +$3.2K 0.01% 782
2020
Q4
$53K Hold
162
0.01% 730
2020
Q3
$45K Hold
162
0.01% 694
2020
Q2
$39K Sell
162
-19
-10% -$3.81K 0.01% 813
2020
Q1
$28K Sell
181
-80
-31% -$13.3K ﹤0.01% 1148
2019
Q4
$43K Buy
261
+135
+107% +$25K 0.01% 1414
2019
Q3
$20K Sell
126
-171
-58% -$37K ﹤0.01% 1597
2019
Q2
$74K Buy
297
+2
+0.7% +$531 0.01% 1023
2019
Q1
$81K Buy
295
+170
+136% +$56.5K 0.01% 929
2018
Q4
$38K Hold
125
0.01% 984
2018
Q3
$53K Hold
125
0.02% 633
2018
Q2
$49K Hold
125
0.02% 663
2018
Q1
$34K Hold
125
0.01% 759
2017
Q4
$21K Hold
125
0.01% 906
2017
Q3
$19K Buy
125
+15
+14% +$2.27K 0.01% 928
2017
Q2
$13K Hold
110
0.01% 1025
2017
Q1
$12K Buy
110
+23
+26% +$2.67K 0.01% 1025
2016
Q4
$9K Sell
87
-29
-25% -$3.36K ﹤0.01% 1066
2016
Q3
$13K Hold
116
0.01% 957
2016
Q2
$11K Buy
116
+13
+13% +$1.29K 0.01% 980
2016
Q1
$8K Buy
+103
New +$8.7K 0.01% 1051

Other funds holding ABMD

Quadrant Capital Group's ABMD Position: Q4 2022 in Review

Quadrant Capital Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 231 shares — an estimated $57K sold.

Quadrant Capital Group first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $81K in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Quadrant Capital Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 231 Abiomed Inc shares in Q4 2022, an estimated $57K.
  • Quadrant Capital Group first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Quadrant Capital Group's Abiomed Inc position peaked at $81K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.